Dova Pharmaceuticals (DOVA) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts DOVA Hot Sheet
Join SI Premium – FREE
Dova Pharmaceuticals (NASDAQ: DOVA) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Dova Pharmaceuticals (DOVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Investing.com’s stocks of the week
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
